Approximating the Operating Characteristics of Bayesian Uncertainty Directed Trial Designs.

Bayesian response adaptive clinical trials are currently evaluating experimental therapies for several diseases. Adaptive decisions, such as pre-planned variations of the randomization probabilities, attempt to accelerate the development of new treatments. The design of response adaptive trials, in most cases, requires time consuming simulation studies to describe operating characteristics, such as type I/II error rates, across plausible scenarios. We investigate large sample approximations of pivotal operating characteristics in Bayesian Uncertainty directed trial Designs (BUDs). A BUD trial utilizes an explicit metric u to quantify the information accrued during the study on parameters of interest, for example the treatment effects. The randomization probabilities vary during time to minimize the uncertainty summary u at completion of the study. We provide an asymptotic analysis (i) of the allocation of patients to treatment arms and (ii) of the randomization probabilities. For BUDs with outcome distributions belonging to the natural exponential family with quadratic variance function, we illustrate the asymptotic normality of the number of patients assigned to each arm and 1 ar X iv :2 10 5. 11 17 7v 1 [ st at .M E ] 2 4 M ay 2 02 1 of the randomization probabilities. We use these results to approximate relevant operating characteristics such as the power of the BUD. We evaluate the accuracy of the approximations through simulations under several scenarios for binary, time-to-event and continuous outcome models.

[1]  William F. Rosenberger,et al.  Central limit Theorem for an Adaptive Randomly Reinforced Urn Model , 2015, 1502.06130.

[2]  Li-Xin Zhang,et al.  Central Limit Theorems of a Recursive Stochastic Algorithm with Applications to Adaptive Designs , 2016, 1602.05708.

[3]  Donald A. Berry,et al.  Bandit Problems: Sequential Allocation of Experiments. , 1986 .

[4]  Lorenzo Trippa,et al.  Bayesian response‐adaptive designs for basket trials , 2017, Biometrics.

[5]  H. Kushner,et al.  Stochastic Approximation and Recursive Algorithms and Applications , 2003 .

[6]  William F. Rosenberger,et al.  RANDOMIZED URN MODELS AND SEQUENTIAL DESIGN , 2002 .

[7]  Lorenzo Trippa,et al.  Bayesian Uncertainty Directed Trial Designs , 2018, Journal of the American Statistical Association.

[8]  Peter Müller,et al.  Bayesian Optimal Design for Phase II Screening Trials , 2008, Biometrics.

[9]  Bradley P. Carlin,et al.  Bayesian Adaptive Methods for Clinical Trials , 2010 .

[10]  Robert L. Wolpert,et al.  Statistical Inference , 2019, Encyclopedia of Social Network Analysis and Mining.

[11]  Lorenzo Trippa,et al.  Bayesian Baskets: A Novel Design for Biomarker-Based Clinical Trials. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  Feifang Hu,et al.  Asymptotics in randomized urn models , 2005 .

[13]  D. Berry Bayesian Statistics and the Efficiency and Ethics of Clinical Trials , 2004 .

[14]  Jay Bartroff,et al.  Approximate Dynamic Programming and Its Applications to the Design of Phase I Cancer Trials , 2010, 1011.6509.

[15]  Michael Woodroofe,et al.  Central Limit Theorems for Doubly Adaptive Biased Coin Designs , 1995 .

[16]  C. Morris Natural Exponential Families with Quadratic Variance Functions , 1982 .

[17]  D. Berry,et al.  Adaptive assignment versus balanced randomization in clinical trials: a decision analysis. , 1995, Statistics in medicine.

[18]  Benjamin Van Roy,et al.  Learning to Optimize via Information-Directed Sampling , 2014, NIPS.

[19]  D. Berry,et al.  I‐SPY 2: An Adaptive Breast Cancer Trial Design in the Setting of Neoadjuvant Chemotherapy , 2009, Clinical pharmacology and therapeutics.

[20]  Feifang Hu,et al.  Efficient randomized-adaptive designs , 2009, 0908.3435.

[21]  Donald A. Berry,et al.  Modified Two-Armed Bandit Strategies for Certain Clinical Trials , 1978 .

[22]  C. Assaid,et al.  The Theory of Response-Adaptive Randomization in Clinical Trials , 2007 .

[23]  Michael D. Smith,et al.  Adaptive Bayesian Designs for Dose-Ranging Drug Trials , 2002 .

[24]  C. Morris Natural Exponential Families with Quadratic Variance Functions: Statistical Theory , 1983 .

[25]  J. Wason,et al.  A comparison of Bayesian adaptive randomization and multi‐stage designs for multi‐arm clinical trials , 2014, Statistics in medicine.

[26]  Peter Müller,et al.  A Bayesian Decision-Theoretic Dose-Finding Trial , 2006, Decis. Anal..

[27]  Sophie Laruelle,et al.  Randomized urn models revisited using Stochastic Approximation , 2011, 1101.2786.

[28]  N. D’Esopo,et al.  STREPTOMYCIN TREATMENT OF PULMONARY TUBERCULOSIS , 1998, The Journal of clinical investigation.

[29]  P. Diaconis,et al.  Conjugate Priors for Exponential Families , 1979 .

[30]  Richard A. Johnson Asymptotic Expansions Associated with Posterior Distributions , 1970 .

[31]  Feifang Hu,et al.  Asymptotic theorems for urn models with nonhomogeneous generating matrices , 1999 .

[32]  Feifang Hu,et al.  Asymptotic properties of doubly adaptive biased coin designs for multitreatment clinical trials , 2003 .

[33]  L. J. Wei,et al.  The Generalized Polya's Urn Design for Sequential Medical Trials , 1979 .

[34]  Lorenzo Trippa,et al.  Bayesian uncertainty‐directed dose finding designs , 2019, Journal of the Royal Statistical Society: Series C (Applied Statistics).

[35]  Pierre Priouret,et al.  Adaptive Algorithms and Stochastic Approximations , 1990, Applications of Mathematics.